Related Experiment Video
Updated: May 11, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Current management of sickle cell anemia
Patrick T McGann1, Alecia C Nero, Russell E Ware
1Texas Children's Center for Global Health, Houston, Texas 77030, USA.
Insights
Early diagnosis and comprehensive management are crucial for sickle cell anemia (SCA). This includes newborn screening, prophylactic treatments, and evolving preventive therapies like hydroxyurea to improve outcomes.
Area of Science:
- Hematology
- Pediatrics
- Genetics
Background:
- Sickle cell anemia (SCA) is a genetic blood disorder requiring early diagnosis for effective management.
- Neonatal screening programs are vital for identifying infants with SCA at birth.
Purpose of the Study:
- To outline the essential components of early and ongoing management for sickle cell anemia.
- To highlight the shift towards preventive therapies in SCA treatment.
Main Methods:
- Early diagnosis through newborn screening.
- Prophylactic penicillin and pneumococcal immunizations.
- Family education for early complication recognition.
- Periodic specialist evaluations including transcranial Doppler screenings.
- Assessment for parenchymal organ damage.
Main Results:
- Early identification enables prompt initiation of life-saving prophylactic measures.
- Comprehensive care reduces the risk of sepsis and stroke.
- Preventive strategies, including blood transfusions and hydroxyurea, are transforming SCA management.
Conclusions:
- Optimal sickle cell anemia management hinges on early diagnosis and a proactive, multidisciplinary approach.
- The paradigm is shifting from managing acute events to implementing long-term preventive therapies for better patient outcomes.
Abstract:
Proper management of sickle cell anemia (SCA) begins with establishing the correct diagnosis early in life, ideally during the newborn period. The identification of affected infants by neonatal screening programs allows early initiation of prophylactic penicillin and pneumococcal immunizations, which help prevent overwhelming sepsis. Ongoing education of families promotes the early recognition of disease-released complications, which allows prompt and appropriate medical evaluation and therapeutic intervention. Periodic evaluation by trained specialists helps provide comprehensive care, including transcranial Doppler examinations to identify children at risk for primary stroke, plus assessments for other parenchymal organ damage as patients become teens and adults. Treatment approaches that previously highlighted acute vaso-occlusive events are now evolving to the concept of preventive therapy. Liberalized use of blood transfusions and early consideration of hydroxyurea treatment represent a new treatment paradigm for SCA management.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Heart Failure V: Medical Management
Acute Coronary Syndrome V: Nursing Management
Myocarditis IV: Nursing Management
Chronic Kidney Disease IV: Nursing Management
Cardiomyopathy VI: Nursing Management
